Status:

NOT_YET_RECRUITING

Immunoparalysis After Pancreaticoduodenectomy

Lead Sponsor:

Hospices Civils de Lyon

Conditions:

Pancreatic Ductal Adenocarcinoma (mPDAC)

Pancreatic Head Tumour

Eligibility:

All Genders

18+ years

Brief Summary

By 2030, pancreatic adenocarcinoma could become the second leading cause of cancer-related death in France. To date, Pancreaticoduodenectomy (PD) is the standard treatment for resectable adenocarcinom...

Eligibility Criteria

Inclusion

  • Any patient undergoing a Pancreaticoduodenectomy in one of the four participating centers for a benign or malignant tumor of the pancreatic head

Exclusion

  • Age \< 18 years
  • Pregnant, postpartum, or breastfeeding women
  • Indication other than tumor-related (e.g., chronic pancreatitis)
  • Patient with an infectious syndrome at the time of inclusion
  • Preoperative immunosuppression
  • Immunosuppressive disease other than cancer:
  • Congenital or acquired immune deficiency
  • Functional hyposplenism or asplenia, patient under long-term antibiotic prophylaxis for this reason
  • Patient with HIV (and CD4 \< cells/mm³)
  • Aplasia defined by circulating neutrophil count \< 500 cells/mm³
  • Immunosuppressive treatment other than chemotherapy : Biotherapy, Corticosteroid therapy \>10 mg/day or cumulative dose \>700 mg prednisolone equivalent : Patient expected to receive immunosuppressive treatment within the first 7 postoperative days
  • Individuals deprived of liberty by judicial or administrative decisio
  • Adults under legal protection (guardianship or curatorship)
  • Individuals not affiliated with a social security scheme or an equivalent coverage
  • Refusal to participate in the study

Key Trial Info

Start Date :

September 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT07144917

Start Date

September 1 2025

End Date

December 1 2026

Last Update

August 28 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Julie PERINEL

Lyon, France, 69003

2

Xavier MULLER

Lyon, France, 69004

3

Aurélien DUPRE

Lyon, France, 69008

4

Jean-Christophe LIFANTE

Pierre-Bénite, France, 69495